Loading...
XTAI
4155
Market cap70mUSD
Jul 09, Last price  
15.60TWD
1D
-0.64%
1Q
19.54%
Jan 2017
-37.07%
IPO
-43.58%
Name

OK Biotech Co Ltd

Chart & Performance

D1W1MN
XTAI:4155 chart
P/E
27.38
P/S
1.45
EPS
0.57
Div Yield, %
1.92%
Shrs. gr., 5y
10.57%
Rev. gr., 5y
0.95%
Revenues
1.56b
-6.81%
280,794,000405,990,000502,536,000656,695,0001,074,281,000633,765,000856,551,0001,040,462,0001,233,076,0001,120,346,0001,241,252,0001,484,413,0001,263,378,0001,483,523,0001,191,985,0001,670,033,0001,556,295,000
Net income
82m
-12.26%
49,700,00037,736,00072,340,00096,678,000138,205,00071,364,000110,969,00085,201,000126,809,000161,362,000125,760,000129,728,00031,422,000143,462,0002,948,00093,975,00082,449,000
CFO
320m
+384.91%
6,950,000-19,515,00093,117,00079,173,00087,085,000-33,834,000289,435,000260,724,000102,768,000128,750,00045,177,000147,700,00021,896,000240,526,0002,933,00065,903,000319,568,000
Dividend
Jul 04, 20250.3 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

OK Biotech Co., Ltd., established in 2006 and based in Hsinchu City, Taiwan, is a global producer and vendor of blood glucose meters. Its product line further encompasses nebulizers, glucometers, blood sugar meters, blood glucose test strips, and personal sound amplifiers.
IPO date
Dec 30, 2010
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT